Adcist 50 Injection
Marketer
Adley Formulations
Salt Composition
Cisplatin (50mg)
Overview Adcist 50 Injection
Oncaspar 50 Injection, a prescription medication, treats ovarian, cervical, and testicular cancers. Its mechanism involves inhibiting or decelerating cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse events. While therapeutic effects might not be immediately apparent (weeks or months), discontinue use only as directed. Common side effects include injection site inflammation (pain, swelling, redness), nausea, and vomiting. Serious side effects, such as hearing impairment or damage, necessitate pre- and ongoing hearing assessments. The medication can lower blood cell counts (red and white), raising infection risk. Regular blood tests monitor blood cell levels and assess heart, liver, and kidney function. Pre-treatment disclosure of any kidney disease history is vital, given the drug's renal impact. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Given its potential for male infertility, sperm banking should be discussed with a physician before treatment commences.
Primary Ingredients of Adcist 50 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Adcist 50 Injection
Cancers affecting the ovaries, cervix, and testes.
Major Benefits of Adcist 50 Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Adcist 50 Injection:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Adcist 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Adcist 50 Injection works:
Oncaspar 50 Injection is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of malignant cells, thus inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Adcist 50 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Adcist 50 Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Adcist 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Adcist 50 Injection can induce adverse reactions, including drowsiness and nausea, potentially impairing driving ability.
KidneyCAUTION
Patients with impaired kidney function should receive Adcist 50 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Adcist 50 Injection is contraindicated in individuals with severely compromised kidney function.
LiverSAFE IF PRESCRIBED
The use of Adcist 50 Injection in individuals with liver impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Adcist 50 Injection :
Should you forget a scheduled Adcist 50 Injection, seek your physician's advice.
Facts to Know About Adcist 50 Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Platinum-based Anticancer Agents |
3,018 People bought this recently